Skip to main content
SpringerLink
Log in

Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Objective

Whether the oncogenic human papillomavirus (HPV) infection, especially infection with the most common subtypes 16 or 18, is related to prostate carcinogenesis remains conflicting. A meta-analysis with updated data was performed to obtain a more precise estimate of the association between them.

Methods

Eligible studies were retrieved via both computer searches and review of references. The relation of HPV-16 or HPV-18 infection to prostate cancer (PC) was quantified separately. Stratified analyses based on HPV detection methods and geographic regions were also performed. Estimates of OR with 95% CI were summarized using the fixed-effect or random-effect models as appropriate.

Results

Twenty-five eligible studies were retrieved. All the 25 studies were assigned for exploring the relation of HPV-16 infection to PC, while 13 studies provided additional information on HPV-18 simultaneously. In the overall estimates, the pooled OR indicated no significant increase of PC risk related with either HPV-16 (OR 1.09; 95% CI 0.97–1.23; P heterogeneity = 0.135) or HPV-18 (OR 1.05; 95% CI 0.89–1.24; P heterogeneity = 0.314) infection. Further quantitative assay of stratified data could also not yield any significant result, except the stratified analysis on HPV-16 DNA detection, which revealed higher HPV-16 DNA prevalence in PC cases (OR 1.54; 95% CI 1.07–2.20; P heterogeneity = 0.130).

Conclusions

Even though the overall estimates did not provide a supportive evidence for the causal role of HPV in prostate carcinogenesis, higher HPV-16 DNA prevalence in PC cases from the stratified analysis still indicated a potential association between HPV infection and PC risk in our meta-analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

HPV:

Human papillomavirus

PC:

Prostate cancer

OR:

Odds ratio

CI:

Confidence interval

References

  1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59(4):225–249

    Article  PubMed  Google Scholar 

  2. Shavers VL, Underwood W, Moser RP (2009) Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med 37(1):64–67

    Article  PubMed  Google Scholar 

  3. Strickler HD, Goedert JJ (2001) Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev 23(1):144–151

    PubMed  CAS  Google Scholar 

  4. Hoffman LJ, Bunker CH, Pellett PE et al (2004) Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 189(1):15–20

    Article  PubMed  Google Scholar 

  5. Taylor ML, Mainous AG 3rd, Wells BJ (2005) Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 37(7):506–512

    PubMed  Google Scholar 

  6. Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ (2005) Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19(4):469–483

    Article  PubMed  CAS  Google Scholar 

  7. Daling JR, Madeleine MM, Johnson LG et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101(2):270–280

    Article  PubMed  Google Scholar 

  8. Dennis LK, Dawson DV (2002) Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13(1):72–79

    Article  PubMed  Google Scholar 

  9. Dennis LK, Lynch CF, Torner JC (2002) Epidemiologic association between prostatitis and prostate cancer. Urology 60(1):78–83

    Article  PubMed  Google Scholar 

  10. Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A (1996) Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and -18 DNA. Cancer Lett 100(1–2):47–54

    Article  PubMed  CAS  Google Scholar 

  11. Choo CK, Ling MT, Chan KW et al (1999) Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 40(3):150–158

    Article  PubMed  CAS  Google Scholar 

  12. Moyret-Lalle C, Marcais C, Jacquemier J et al (1995) ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 64(2):124–129

    Article  PubMed  CAS  Google Scholar 

  13. Dillner J, Knekt P, Boman J et al (1998) Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 75(4):564–567

    Article  PubMed  CAS  Google Scholar 

  14. Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U (1999) Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 59(4):823–825

    PubMed  CAS  Google Scholar 

  15. Carozzi F, Lombardi FC, Zendron P et al (2004) Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 19(4):257–261

    PubMed  CAS  Google Scholar 

  16. Korodi Z, Dillner J, Jellum E et al (2005) Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 14(12):2952–2955

    Article  PubMed  CAS  Google Scholar 

  17. Leiros GJ, Galliano SR, Sember ME et al (2005) Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 5:15

    Article  PubMed  Google Scholar 

  18. Sutcliffe S, Giovannucci E, Gaydos CA et al (2007) Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 16(8):1573–1580

    Article  PubMed  CAS  Google Scholar 

  19. Huang WY, Hayes R, Pfeiffer R et al (2008) Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17(9):2374–2381

    Article  PubMed  CAS  Google Scholar 

  20. Sutcliffe S, Viscidi RP, Till C et al (2010) Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 19(2):614–618

    Google Scholar 

  21. Aghakhani A, Hamkar R, Parvin M et al (2011) The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis 43:64–69

    Google Scholar 

  22. Sitas F, Urban M, Stein L et al (2007) The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect agents cancer 2:6

    Article  PubMed  Google Scholar 

  23. May M, Kalisch R, Hoschke B et al (2008) Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance? Der Urologe Ausg 47(7):846–852

    CAS  Google Scholar 

  24. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826

    PubMed  CAS  Google Scholar 

  25. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    PubMed  CAS  Google Scholar 

  26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  27. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    PubMed  CAS  Google Scholar 

  28. McNicol PJ, Dodd JG (1990) Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol 28(3):409–412

    PubMed  CAS  Google Scholar 

  29. Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N (1991) Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 84(2):235–236

    Article  PubMed  CAS  Google Scholar 

  30. McNicol PJ, Dodd JG (1991) High prevalence of human papillomavirus in prostate tissues. J Urol 145(4):850–853

    PubMed  CAS  Google Scholar 

  31. Anwar K, Nakakuki K, Shiraishi T et al (1992) Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52(21):5991–5996

    PubMed  CAS  Google Scholar 

  32. Ibrahim GK, Gravitt PE, Dittrich KL et al (1992) Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 148(6):1822–1826

    PubMed  CAS  Google Scholar 

  33. Rotola A, Monini P, Di Luca D et al (1992) Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 52(3):359–365

    Article  PubMed  CAS  Google Scholar 

  34. Tu H, Jacobs SC, Mergner WJ, Kyprianou N (1994) Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 44(5):726–731

    Article  PubMed  CAS  Google Scholar 

  35. Anderson M, Handley J, Hopwood L et al (1997) Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J Med Virol 52(1):8–13

    Article  PubMed  CAS  Google Scholar 

  36. Gherdovich S, Barbacci P, Mitrione MP et al (1997) Detection of the human papillomavirus in hyperplastic and cancerous prostatic tissue with PCR. Minerva urologica e nefrologica Italian J Urol Nephrol 49(2):73–77

    CAS  Google Scholar 

  37. Terris MK, Peehl DM (1997) Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 50(1):150–156

    Article  PubMed  CAS  Google Scholar 

  38. Noda T, Sasagawa T, Dong Y et al (1998) Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 26(3):165–169

    Article  PubMed  CAS  Google Scholar 

  39. Strickler HD, Burk R, Shah K et al (1998) A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 82(6):1118–1125

    Article  PubMed  CAS  Google Scholar 

  40. Hayes RB, Pottern LM, Strickler H et al (2000) Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 82(3):718–725

    Article  PubMed  CAS  Google Scholar 

  41. Hisada M, Rabkin CS, Strickler HD et al (2000) Human papillomavirus antibody and risk of prostate cancer. JAMA 283(3):340–341

    Article  PubMed  CAS  Google Scholar 

  42. Adami HO, Kuper H, Andersson SO, Bergstrom R, Dillner J (2003) Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 12(9):872–875

    PubMed  Google Scholar 

  43. Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL (2003) Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 12(8):763–768

    PubMed  Google Scholar 

  44. Bergh J, Marklund I, Gustavsson C et al (2007) No link between viral findings in the prostate and subsequent cancer development. Br J Cancer 96(1):137–139

    Article  PubMed  CAS  Google Scholar 

  45. Gazzaz FS, Mosli HA (2009) Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 30(5):633–637

    PubMed  Google Scholar 

  46. Silvestre RV, Leal MF, Demachki S et al (2009) Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Memorias do Instituto Oswaldo Cruz 104(4):665–667

    Article  PubMed  Google Scholar 

  47. Kaplan HS (1961) The role of cell differentiation as a determinant of susceptibility to virus carcinogenesis. Cancer Res 21:981–983

    PubMed  CAS  Google Scholar 

  48. Chaturvedi AK (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 46(4 Suppl):S20–S26

    Article  PubMed  Google Scholar 

  49. Kong DB, Zheng XY, Xie LP, Sima N (2009) Is prostate cancer an HPV-associated lesion? Med Hypotheses 72(1):101

    Article  PubMed  Google Scholar 

  50. Colon-Lopez V, Ortiz AP, Palefsky J (2010) Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. Puerto Rico Health Sci J 29(3):232–240

    Google Scholar 

  51. Castellsague X, Schneider A, Kaufmann AM, Bosch FX (2009) HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 115(3 Suppl):S15–S23

    Article  PubMed  CAS  Google Scholar 

  52. Mammas IN, Vageli D, Spandidos DA (2008) Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncol Rep 20(1):141–145

    PubMed  Google Scholar 

  53. Srinivasan M, Taioli E, Ragin CC (2009) Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis. Carcinogenesis 30(10):1722–1728

    Article  PubMed  CAS  Google Scholar 

  54. Iwasaka T, Hayashi Y, Yokoyama M et al (1992) ‘Hit and run’ oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand 71(3):219–223

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by National Key Technology R&D Program (No. 2008BAH27B00).

Author information

Authors and Affiliations

  1. Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou, 310003, Zhejiang Province, China

    Y. Lin, Q. Mao, X. Zheng, K. Yang, H. Chen, C. Zhou & L. Xie

Authors
  1. Y. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Q. Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Xie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, Y., Mao, Q., Zheng, X. et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Ir J Med Sci 180, 497–503 (2011). https://doi.org/10.1007/s11845-011-0692-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-011-0692-6

Keywords

Search

Navigation